Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2017 /
Results of the MONALEESA 7 trial

5th - 9th Dec 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.12.17
Views: 1479

Prof Debu Tripathy - MD Anderson Cancer Center, Houston, USA

Prof Debu Tripathy speaks with ecancer at SABCS 2017 about the results of the MONALEESA 7 trial of ribociclib for pre/perimenopausal women with HR advanced breast cancer.

He details the improved mPFS and ORR, and considers how best to manage toxicity.

For more on these findings, watch Prof Tripathy present the results at a press session here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation